Market closed

Bristol-Myers Squibb/$BMY

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Bristol-Myers Squibb

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Ticker

$BMY

Trading on

NYSE

Industry

Pharmaceuticals

Employees

34,100

BMY Metrics

BasicAdvanced
$121B
Market cap
-
P/E ratio
-$3.58
EPS
0.44
Beta
$2.40
Dividend rate
4.01%
Dividend yield
$121B
0.44
$59.53
$39.35
11M
$2.40
1.24
1.016
291.826
299.052
5.09%
6.07%
-31.33%
2.555
7.08
-3.84
8.781
4.01%
4.01%
5.56%
-190.85%
1.42%
13.96%
6.98%

What the Analysts think about BMY

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Bristol-Myers Squibb stock.

BMY Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

BMY Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BMY

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bristol-Myers Squibb stock?

Bristol-Myers Squibb (BMY) has a market cap of $121B as of November 13, 2024.

What is the P/E ratio for Bristol-Myers Squibb stock?

The price to earnings (P/E) ratio for Bristol-Myers Squibb (BMY) stock is 0 as of November 13, 2024.

Does Bristol-Myers Squibb stock pay dividends?

Yes, the Bristol-Myers Squibb (BMY) stock pays dividends to shareholders. As of November 13, 2024, the dividend rate is $2.4 and the yield is 4.01%. Bristol-Myers Squibb has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Bristol-Myers Squibb dividend payment date?

The next Bristol-Myers Squibb (BMY) dividend payment date is unconfirmed.

What is the beta indicator for Bristol-Myers Squibb?

Bristol-Myers Squibb (BMY) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.